Here's the new FDA-approved pill that's an alternative to liquid colonoscopy solutions

The FDA approved Sebela Pharmaceuticals' colonoscopy preparation tablet Sutab, the company announced Nov. 10. 

The tablet is a sulfate-based preparation that's an alternative to liquid solutions. Sebela developed the pill for patients who have had difficulty completing preparation solutions in the past. 

In a clinical trial with 515 patients, 92 percent of patients achieved a successful level of bowel cleansing after taking Sutab, and 78 percent of patients said they'd take it again for a future colonoscopy. 

In a second trial, 92 percent to 95 percent achieved successful cleansing in all segments of the colon. 

Sutab will be available to patients on Jan. 1, 2021.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers